Home » Stocks » McKesson

McKesson Corporation (MCK)

Stock Price: $159.79 USD 9.63 (6.41%)
Updated Aug 3, 2020 3:51 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 25.90B
Revenue (ttm) 231.05B
Net Income (ttm) 900.00M
Shares Out 162.12M
EPS (ttm) 4.96
PE Ratio 32.21
Forward PE 10.71
Dividend $1.68
Dividend Yield 1.05%

Stock Quote

Trading Day Aug 3, 2020
Last Price $159.79
Previous Close $150.16
Change ($) 9.63
Change (%) 6.41%
Day's Open 156.00
Day's Range 154.54 - 160.37
Day's Volume 1,218,808
52-Week Range 112.60 - 172.18

More Stats

Market Cap 25.90B
Enterprise Value 31.29B
Earnings Date (est) Aug 3, 2020
Ex-Dividend Date May 29, 2020
Shares Outstanding 162.12M
Float 161.72M
EPS (basic) 4.98
EPS (diluted) 4.96
FCF / Share 21.37
Dividend $1.68
Dividend Yield 1.05%
Earnings Yield 3.10%
FCF Yield 14.93%
Payout Ratio 32.50%
Shares Short 2.42M
Short Ratio 1.98
Short % of Float 1.49%
Beta 0.84
PE Ratio 32.21
Forward PE 10.71
P/FCF Ratio 6.70
PS Ratio 0.11
PB Ratio 4.90
Revenue 231.05B
Operating Income 2.49B
Net Income 900.00M
Free Cash Flow 3.87B
Net Cash -5.39B
Net Cash / Share -33.22
Gross Margin 5.20%
Operating Margin 1.08%
Profit Margin 0.40%
FCF Margin 1.67%
ROA 2.94%
ROE 13.74%
ROIC 7.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (18)

Buy 10
Overweight 1
Hold 7
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$175.87*
(10.07% upside)
Low
147
Current: $159.79
High
200
Target: 175.87
*Average 12-month price target from 15 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue231,051214,319208,357198,533190,884179,045137,392122,196122,321112,084
Revenue Growth7.81%2.86%4.95%4.01%6.61%30.32%12.44%-0.1%9.13%-
Gross Profit12,02311,75411,18411,27111,41611,4118,3526,8816,4025,970
Operating Income2,4898866163,1753,4422,9682,4392,2662,1241,821
Net Income90034.0067.005,0702,2581,4761,2631,3381,4031,202
Shares Outstanding181196208221230232229235246258
Earnings Per Share4.950.170.3222.739.706.275.415.595.594.57
EPS Growth2811.76%-46.88%-98.59%134.33%54.7%15.9%-3.22%0%22.32%-
Dividend Per Share1.621.511.301.121.080.960.920.800.800.72
Dividend Growth7.28%16.15%16.07%3.7%12.5%4.35%15%0%11.11%-
Operating Cash Flow4,3744,0364,3454,7443,6723,1123,1362,4832,9502,338
Capital Expenditures-506-557-580-562-677-545-419-400-398-388
Free Cash Flow3,8683,4793,7654,1822,9952,5672,7172,0832,5521,950
Cash & Equivalents4,0152,9812,6722,7834,0485,3414,1932,4563,1493,612
Total Debt9,4017,5957,8808,5458,1149,84410,5944,8733,9804,004
Net Cash / Debt-5,386-4,614-5,208-5,762-4,066-4,503-6,401-2,417-831-392
Assets61,24759,67260,38160,96956,52353,87051,75934,78633,09330,886
Liabilities55,93851,38550,32449,69647,51545,78541,44127,71626,26223,666
Book Value5,0928,0949,80411,0958,9248,0018,5227,0706,8317,220
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name McKesson Corporation
Country United States
Employees 60,000
CEO Brian Scott Tyler

Stock Information

Ticker Symbol MCK
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Distribution
Unique Identifier NYSE: MCK

Description

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.